Assure Holdings Corp. (IONM)
USD 0.0
(-99.67%)
USD 0.0
(-99.67%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -19.82 Million USD | -23.08% |
| 2022 | -18.18 Million USD | -1499.71% |
| 2021 | -1.39 Million USD | 90.96% |
| 2020 | -15.18 Million USD | -628.78% |
| 2019 | 2.9 Million USD | -44.96% |
| 2018 | 5.14 Million USD | 184.79% |
| 2017 | -6.23 Million USD | -10764.61% |
| 2016 | 4.14 Million USD | -102.87% |
| 2015 | -28.27 Thousand USD | 42.66% |
| 2014 | -49.3 Thousand USD | -23.01% |
| 2013 | -40.08 Thousand USD | 76.63% |
| 2012 | -171.52 Thousand USD | -175.7% |
| 2011 | -62.21 Thousand USD | 8.97% |
| 2010 | -68.34 Thousand USD | 22.87% |
| 2009 | -88.6 Thousand USD | -32.18% |
| 2008 | -67.03 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4.28 Million USD | 34.95% |
| 2024 Q2 | -1.18 Million USD | 39.76% |
| 2023 Q3 | -4.16 Million USD | 18.7% |
| 2023 FY | - USD | -23.08% |
| 2023 Q1 | -3.07 Million USD | 72.16% |
| 2023 Q2 | -5.11 Million USD | -66.3% |
| 2023 Q4 | -8.11 Million USD | -95.18% |
| 2022 Q2 | -6.33 Million USD | -66.75% |
| 2022 Q3 | -3.81 Million USD | 39.67% |
| 2022 Q4 | -11.05 Million USD | -189.37% |
| 2022 Q1 | -3.79 Million USD | -1233.13% |
| 2022 FY | - USD | -1499.71% |
| 2021 Q4 | 335 Thousand USD | -58.44% |
| 2021 Q2 | -1.17 Million USD | 13.21% |
| 2021 Q3 | 806 Thousand USD | 168.54% |
| 2021 FY | - USD | 90.96% |
| 2021 Q1 | -1.35 Million USD | -10.97% |
| 2020 Q2 | -13.64 Million USD | -20172.06% |
| 2020 Q4 | -1.22 Million USD | -112.35% |
| 2020 FY | - USD | -628.78% |
| 2020 Q1 | 68 Thousand USD | 100.77% |
| 2020 Q3 | -575 Thousand USD | 95.79% |
| 2019 Q3 | 4.65 Million USD | -2.58% |
| 2019 Q4 | -8.85 Million USD | -290.27% |
| 2019 FY | - USD | -44.96% |
| 2019 Q1 | 2.33 Million USD | 142.28% |
| 2019 Q2 | 4.77 Million USD | 104.97% |
| 2018 Q1 | 3.29 Million USD | 112.72% |
| 2018 FY | - USD | 184.79% |
| 2018 Q4 | -5.51 Million USD | -244.87% |
| 2018 Q3 | 3.8 Million USD | -12.78% |
| 2018 Q2 | 4.36 Million USD | 32.57% |
| 2017 Q3 | 6.85 Million USD | 227.8% |
| 2017 Q4 | -25.88 Million USD | -477.68% |
| 2017 Q1 | 2.76 Million USD | 11603.95% |
| 2017 FY | - USD | -10764.61% |
| 2017 Q2 | 2.09 Million USD | -24.49% |
| 2016 Q4 | -24.07 Thousand USD | -28.29% |
| 2016 Q1 | -4462.88 USD | 46.2% |
| 2016 FY | - USD | -102.87% |
| 2016 Q2 | -10.43 Thousand USD | -133.86% |
| 2016 Q3 | -18.76 Thousand USD | -79.78% |
| 2015 Q3 | -7728.12 USD | -27.63% |
| 2015 FY | - USD | 42.66% |
| 2015 Q1 | -7039.75 USD | 38.27% |
| 2015 Q2 | -6054.89 USD | 13.99% |
| 2015 Q4 | -8296.02 USD | -7.35% |
| 2014 FY | - USD | -23.01% |
| 2014 Q3 | -8060.53 USD | 62.94% |
| 2014 Q4 | -11.4 Thousand USD | -41.48% |
| 2014 Q1 | -9144.37 USD | 52.04% |
| 2014 Q2 | -21.74 Thousand USD | -137.84% |
| 2013 Q1 | -9106.10 USD | 79.56% |
| 2013 FY | - USD | 76.63% |
| 2013 Q4 | -19.06 Thousand USD | -333.87% |
| 2013 Q3 | -4394.23 USD | 41.38% |
| 2013 Q2 | -7496.01 USD | 17.68% |
| 2012 FY | - USD | -175.7% |
| 2012 Q1 | -41.47 Thousand USD | -1.29% |
| 2012 Q2 | -56.22 Thousand USD | -35.56% |
| 2012 Q3 | -26.82 Thousand USD | 52.29% |
| 2012 Q4 | -44.55 Thousand USD | -66.11% |
| 2011 Q4 | -40.95 Thousand USD | -319.78% |
| 2011 Q1 | -6341.12 USD | 73.93% |
| 2011 Q2 | -5968.90 USD | 5.87% |
| 2011 Q3 | -9755.23 USD | -63.43% |
| 2011 FY | - USD | 8.97% |
| 2010 Q3 | -21.72 Thousand USD | -156.44% |
| 2010 FY | - USD | 22.87% |
| 2010 Q4 | -24.32 Thousand USD | -11.96% |
| 2010 Q2 | -8471.68 USD | 38.64% |
| 2010 Q1 | -13.8 Thousand USD | 76.67% |
| 2009 FY | - USD | -32.18% |
| 2009 Q4 | -59.17 Thousand USD | -891.98% |
| 2009 Q3 | -5965.01 USD | 25.32% |
| 2009 Q2 | -7987.42 USD | 34.89% |
| 2009 Q1 | -12.26 Thousand USD | -2047.11% |
| 2008 FY | - USD | 0.0% |
| 2008 Q3 | -20.13 Thousand USD | 54.61% |
| 2008 Q2 | -44.35 Thousand USD | -1071.57% |
| 2008 Q1 | -3786.07 USD | 0.0% |
| 2008 Q4 | -571.38 USD | 97.16% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Oncology Network, Inc. | -39.35 Million USD | 49.623% |
| ATI Physical Therapy, Inc. | 82.86 Million USD | 123.923% |
| Novo Integrated Sciences, Inc. | -5.84 Million USD | -238.93% |
| Panamera Holdings Corporation | -7.12 Million USD | -178.401% |